Login

Financial Snapshot

Revenue
TTM
$2.371M
Gross Margin
TTM
-95.6%
Net Income
TTM
-$11.49M
Current Assets
2025 Q4
Current Liabilities
2025 Q4
Current Ratio
2025 Q4
252.51%
Total Assets
2025 Q4
Total Liabilities
2025 Q4
Book Value
2025 Q4
$6.081M
Cash
2025 Q4
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$9.447M

Stock Price

Loading...
Market Cap: $5.7675 Million

About Collplant Biotechnologies Ltd

CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. The company is headquartered in Rehovot, Central(Hamerkaz) and currently employs 39 full-time employees. The firm provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).

Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies Peers: Enlivex Ltd Protalix Biotherapeutics Inc Evogene Ltd Gamida Cell Ltd. Urogen Pharma Ltd

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support